Cholesterol 25-Hydroxylase Inhibits Senecavirus A Replication by Enzyme Activity-Dependent and Independent Mechanisms

Huixin Zhu,Junfang Yan,Xing Liu,Liang Li,Wenwen Liu,Xianwei Wang,Ping Jiang,Juan Bai
DOI: https://doi.org/10.1016/j.vetmic.2021.109038
IF: 3.246
2021-01-01
Veterinary Microbiology
Abstract:Cholesterol 25-hydroxylase (CH25 H), as a host restriction factor, has been reported to take a broad-spectrum antiviral effect. However, the role of CH25H in Senecavirus A (SVA) infection remains unknown. In this study, we first demonstrate that overexpression of CH25H inhibits SVA replication. Consistently, knockdown or knockout of the endogens CH25H promotes SVA infection. Further, the anti-SVA effect of 25-hydroxycholesterol (25HC), which is the product of CH25H, operates via inhibition of viral attachment and replication. On the other hand, the CH25H mutant (CH25H-M) lacking hydroxylase activity still restricts SVA infection, which can selectively interact and degrade SVA 3A protein via the ubiquitin-proteasome manner. Altogether, these results suggest that CH25H has an antiviral function in SVA infection and provides an alternative manner to control SVA.
What problem does this paper attempt to address?